» Articles » PMID: 965092

Molecular Forms of Neurotoxins in Proteolytic Clostridium Botulinum Type B Cultures

Overview
Journal Infect Immun
Date 1976 Sep 1
PMID 965092
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A modified purification method was used to isolate the neurotoxin of proteolytic Clostridium botulinum type B strain Lamanna. The preparation was found to be a mixture of two protein forms. They were of molecular weight 152,000 and could not be separated by ion-exchange chromatography or electrophoresis in polyacrylamide gel. One was a single polypeptide chain, and the other was a dichain molecule (nicked toxin) held together by an interchain disulfide bond(s). Trypsinization increased the toxicity of the toxin preparation and converted the single-chain molecules into dichain forms that were indistinguishable from the endogenously generated nicked toxin. A protease of the type B culture, with substrate specificity similar to that of trypsin, did not change detectably the molecular form of unnicked type E toxin, although toxicity was increased. Higher toxicity was obtained when unnicked type E was trypsinized; the resulting preparation contained only nicked toxin molecules.

Citing Articles

Molecular mechanisms of treadmill therapy on neuromuscular atrophy induced via botulinum toxin A.

Tsai S, Chen H, Chang Y, Chen C Neural Plast. 2013; 2013:593271.

PMID: 24327926 PMC: 3845528. DOI: 10.1155/2013/593271.


Immunogenicity of botulinum toxins.

Naumann M, Boo L, Ackerman A, Gallagher C J Neural Transm (Vienna). 2012; 120(2):275-90.

PMID: 23008029 PMC: 3555308. DOI: 10.1007/s00702-012-0893-9.


Endopeptidase activities of botulinum neurotoxin type B complex, holotoxin, and light chain.

Wang H, Riding S, Lindo P, Singh B Appl Environ Microbiol. 2010; 76(19):6658-63.

PMID: 20693440 PMC: 2950459. DOI: 10.1128/AEM.00731-10.


Colony immunoblot assay of botulinal toxin.

Goodnough M, Hammer B, Sugiyama H, Johnson E Appl Environ Microbiol. 1993; 59(7):2339-42.

PMID: 8357267 PMC: 182282. DOI: 10.1128/aem.59.7.2339-2342.1993.


Nature of intracellular type A botulinum neurotoxin.

Krysinski E, Sugiyama H Appl Environ Microbiol. 1981; 41(3):675-8.

PMID: 7013709 PMC: 243758. DOI: 10.1128/aem.41.3.675-678.1981.


References
1.
Hoyem T, Skulberg A . Trypsin inhibitors produced by Clostridium botulinum cultures. Nature. 1962; 195:922-3. DOI: 10.1038/195922a0. View

2.
Das Gupta B, Sugiyama H . Role of a protease in natural activation of Clostridium botulinum neurotoxin. Infect Immun. 1972; 6(4):587-90. PMC: 422579. DOI: 10.1128/iai.6.4.587-590.1972. View

3.
Dasgupta B, Sugiyama H . Isolation and characterization of a protease from Clostridium botulinum type B. Biochim Biophys Acta. 1972; 268(3):719-29. DOI: 10.1016/0005-2744(72)90276-8. View

4.
Collier R . Diphtheria toxin: mode of action and structure. Bacteriol Rev. 1975; 39(1):54-85. PMC: 413884. DOI: 10.1128/br.39.1.54-85.1975. View

5.
Sugiyama H, Das Gupta R, Yang K . Disulfide-toxicity relationship of botulinal toxin types A, E, and F. Proc Soc Exp Biol Med. 1973; 143(3):589-91. DOI: 10.3181/00379727-143-37372. View